AstraZeneca to sell antibiotics business to Pfizer
August 24, 2016 at 02:15 AM EDT
LONDON, Aug 24 (Reuters) - Pharmaceutical company AstraZeneca said it had agreed to sell its small molecule antibiotics business to Pfizer in a deal that could reach more than $1.5 billion.
